Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
O23 Risankizumab vs ustekinumab for patients with moderat... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
O23 Risankizumab vs ustekinumab for patients with moderate-to-severe crohn’s disease: results from the phase 3b SEQUENCE study
0
Authors
James Lindsay
24 more
James Lindsay
•
Laurent Peyrin–Biroulet
22 more
•
Kamal Patel
Published
June 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Oral Presentations
Topics
Biology
Quantum Mechanics
Physics
Medicine
Epidemiology
Show all topics
DOI
10.1136/gutjnl-2024-bsg.23
